CNR2 and early-onset autosomal dominant Alzheimer disease: CB2 has been shown to play a regulatory role in neuroinflammatory and neurodegenerative diseases such as Alzheimer’s disease (AD), Huntington’s disease (HD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS).